Following the success of our partnership at the 2023 MDA Clinical and Scientific Conference, we are delighted and incredibly excited to announce that representatives of the TREAT-NMD team are flying to Orlando, Florida in March to attend one of the most exciting events in the NMD calendar.
In addition, as a friend of MDA, TREAT-NMD are extremely privileged to be partnering once again at this year’s conference on a CE accredited session to be delivered to delegates as part of the Clinical Considerations track. The session will be chaired by Jeffrey M. Statland (University of Kansas Medical Center, USA), accompanied by expert clinicians, who will focus on providing An Overview of Therapeutics for FSHD. MDA and TREAT-NMD are excited to be working alongside the FSHD Society to provide clinical education and insight into this disease area.
The MDA Clinical & Scientific Conference is being held March 3-6, 2024, in Orlando, FL at the Hilton Orlando. The conference will offer the NMD professional community a first-in-class conference both in-person as well as virtually. The 2024 Conference will explore all aspects of pre-clinical, translational, and clinical research and care across NMD to support the development of better care and treatments for the NMD community.
The MDA are very excited to be welcoming back delegates for this year’s event and wish to invite attendees from across the globe. If you’re interested in registering for the conference, please visit the conference website at MDA Conference 2024.
